Recursion Pharmaceuticals, Inc.
USD3.69
+0.17 (+4.83%)
CEO
Najat Khan
IPO Date
2021-04-16
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$3.61
Prev. Close
$3.52
Day Low
$3.55
Day High
$3.74
52W Low
$2.77
52W High
$7.18
Market Cap
$1.65B
Volume
22.83M
| 88,424 |
| $0.00 |
| 22 Jun 2026 | Michor Franziska | director | A-Award | Acquired | 88,424 | $0.00 |
| 22 Jun 2026 | Sun Elaine D | director | A-Award | Acquired | 88,424 | $0.00 |
| 22 Jun 2026 | Dar Zavain | director | A-Award | Acquired | 88,424 | $0.00 |
| 22 Jun 2026 | Li Dean Y | director | A-Award | Acquired | 88,424 | $0.00 |
| 22 Jun 2026 | Bumpus Namandje | director | A-Award | Acquired | 88,424 | $0.00 |
| 22 Jun 2026 | Bumpus Namandje | director | S-Sale | Disposed | 3,963 | $3.18 |
| 17 Jun 2026 | Taylor Ben R | Chief Financial Officer | F-InKind | Disposed | 5,396 | $3.15 |
| 5 Jun 2026 | Gibson Christopher | director | C-Conversion | Acquired | 40,000 | $0.00 |